Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1447 of 6351
-
New TB tests aim to find more cases in indonesia
Diagnosis Not yet recruitingThe goal of this cluster-randomised controlled trial (CRCT) is to learn whether the use of new non-sputum-based diagnostic tests and other intervention components for tuberculosis (TB) diagnosis in healthcare facilities (HCF) can increase TB notifications. The main questions it a…
Sponsor: Universitas Padjadjaran • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
AI-Powered sleep therapy could boost brain health in seniors
Symptom relief Not yet recruitingThis double blind randomized clinical trial on older independent-living healthy individuals with symptoms of insomnia will harness Cognitive Behavioral Therapy for Insomnia (CBT-I) and augment it with ambulatory data collection devices, personalized digital content, and smart sou…
Phase 2 • Sponsor: Proactive Life Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
HPV pill trial aims to clear precancerous cells without surgery
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and efficacy of Papillex® on the regression of abnormal cervical cells caused by HPV in women with a cervical intraepithelial neoplasia (CIN) 1 or 2 diagnosis. The main question it aims to answer is: Is there a differe…
Sponsor: Papillex Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Cockroach extract may shield cancer patients from radiation burns
Prevention Recruiting nowTo evaluate the efficacy and safety of topical Periplaneta americana-derived Meilian Fuxin Solution for the prevention of radiation dermatitis in patients undergoing radiotherapy.
Phase 2/3 • Sponsor: West China Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Shorter blood thinner course after stents may cut bleeding risk
Disease control Not yet recruitingPatients with acute coronary syndrome (ACS) who have both high ischemic risk and high bleeding risk represent a challenging population following percutaneous coronary intervention (PCI), as prolonged dual antiplatelet therapy (DAPT) may reduce ischemic events but increases bleedi…
Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New antibody trial aims to tame Sjögren's symptoms
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase II study designed to evaluate the efficacy and safety of ESG206 in participants with primary Sjögren's syndrome.
Phase 2 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could skipping the breathing tube make lung surgery recovery easier?
Symptom relief Not yet recruitingThis is a large clinical study that compares two different types of anesthesia for patients undergoing a specific kind of minimally invasive lung surgery (thoracoscopic sublobar resection) to remove small, early-stage lung nodules. The study aims to find out if a newer anesthesi…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New drug cocktail aims to tackle Hard-to-Treat colorectal cancer
Disease control Recruiting nowIn this single-center,open-label, randomized, phase II study, the efficacy and feasibility of GSL synthetase inhibitor in combination with immune checkpoint inhibitor and/or regorafenib therapeutic regimen will be evaluated in patients with advanced/metastatic proficient mismatch…
Phase 2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New gut implant aims to tackle diabetes and obesity without surgery
Disease control Not yet recruitingApproval study Trans-Duodenal Barrier The goal of this clinical trial is to determin the safety and performance of the newly developed Trans-Duodenal Barrier in adult Tryp 2 diabetic and obese patients. The Trans-Duodenal Barrier is an endoscopic implant which can be placed to t…
Sponsor: Trans-Duodenal Concepts GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Brain zaps to sharpen bipolar minds: new trial tests quick fix for foggy thinking
Symptom relief Not yet recruitingBipolar disorder is a highly disabling psychiatric illness, and cognitive impairment is common in patients with bipolar depression as well as during remission, contributing substantially to functional disability and poorer prognosis. Currently, effective interventions specificall…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New monitoring method may help chest trauma patients breathe easier and leave the ventilator sooner
Disease control Not yet recruitingIn our previous study, the investigators analyzed more than 30,000 cases from the National Trauma Center Database and found that 66.4% of patients with severe blunt chest trauma had concurrent rib fractures, 55.87% had multiple fractures (≥4 ribs), and 37.4% had combined pulmonar…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Experimental cell infusion aims to tame childhood autoimmune diseases
Disease control Not yet recruitingThis exploratory, single-arm, open-label study will evaluate the safety and preliminary efficacy of YTS109 cell therapy in pediatric patients with relapsed/refractory autoimmune diseases, including systemic lupus erythematosus, diffuse systemic sclerosis, idiopathic inflammatory …
Phase 1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New imaging agent could sharpen lung nodule diagnosis
Diagnosis Not yet recruitingThe excellent tumor-targeting efficacy of FAP has been confirmed by multiple clinical studies. The results unequivocally establish FAPI as a tumor-targeting ligand with significant potential, demonstrating important application prospects in translational oncology. However, its th…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
More chemo before surgery: better odds for rare thymic cancer?
Disease control Not yet recruitingThis randomized controlled trial compares 6 versus 3 cycles of neoadjuvant chemotherapy in patients with potentially resectable locally advanced thymic epithelial tumors (TETs, WHO type AB/B/C, AJCC TNM stage IIIA-IVA). Patients are randomized 1:1 to receive either 6 or 3 cycles …
Phase 2/3 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New procedure aims to silence pelvic pain for good
Symptom relief Not yet recruitingTranscatheter Embolization of Ovarian Vein and Pelvic Venous Reservoir for Treatment of Pelvic Congestion Syndrome Secondary to May-Thurner Syndrome. This study aims to prospectively evaluate the short-term clinical outcomes and the incidence of post-embolization stenting for re…
Sponsor: Mark Magdy Zekry • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New obesity drug tirzepatide put to the test in paraguay clinic
Disease control Not yet recruitingThis is a Phase 4 observational study evaluating the safety and effectiveness of tirzepatide (T.G.) manufactured by INDUFAR S.A. in 300 patients with obesity treated at the Obesity Unit of Hospital de Clínicas in Paraguay over 12 months. The primary objective is to assess the saf…
Sponsor: LABORATORIOS INDUFAR • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for painful hand and foot skin disease: experimental drug enters trial
Disease control Recruiting nowPalmoplantar pustulosis (PPP) is a chronic and recurrent skin disease, mainly characterized by erythema, pustules and scales on the palms and soles, often accompanied by itching and pain, which seriously affects the quality of life of patients. Currently, the treatment options fo…
Phase 4 • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New eye implant could rival standard glaucoma surgery
Disease control Recruiting nowThe goal of this randomized controlled clinical trial is to learn whether two minimally invasive bleb-forming glaucoma implants can effectively treat adult patients with open-angle glaucoma who require surgical lowering of intraocular pressure (IOP). Specifically, the study evalu…
Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart attack drug may fix 'Hidden' vessel damage
Disease control Not yet recruitingDespite the success of restoration of epicardial blood flow by the primary percutaneous coronary intervention (PPCI), approximately one half of patients with ST-segment elevation myocardial infarction (STEMI) have failed myocardial reperfusion, namely microvascular dysfunction. P…
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New orthosis aims to stop shoulder dislocation in stroke survivors
Prevention OngoingStroke is a leading cause of long-term disability worldwide. During the early stage of recovery after cerebral infarction, reduced muscle tone and muscle weakness in the affected upper limb may lead to shoulder instability and shoulder subluxation, which can subsequently result i…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC